Concepta PLC (LON:FRI)‘s stock had its “buy” rating restated by stock analysts at Peel Hunt in a research report issued on Monday. They currently have a GBX 120 ($1.55) target price on the stock.

FRI has been the topic of several other reports. FinnCap raised their price objective on Concepta PLC from GBX 500 ($6.47) to GBX 690 ($8.92) and gave the company a “corporate” rating in a report on Friday, July 28th. Liberum Capital started coverage on Concepta PLC in a report on Tuesday, August 15th. They issued a “buy” rating and a GBX 850 ($10.99) price objective on the stock. Finally, Numis Securities Ltd raised Concepta PLC to an “add” rating and raised their price objective for the company from GBX 300 ($3.88) to GBX 466 ($6.03) in a report on Thursday, June 22nd.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at

Concepta PLC Company Profile

Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.

Receive News & Stock Ratings for Concepta PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta PLC and related stocks with our FREE daily email newsletter.